New cancer data spark outcry from patient advocatesJanuary 30, 2023OncologyGenitourinary CancerProstate Cancer
People with cancer should be wary of taking dietary supplementsJanuary 23, 2023Lung CancerOncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Oncologists may be too quick to refer patients to palliative careJanuary 18, 2023OncologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
‘Low-value’ prostate cancer screening prevalent in primary careJanuary 9, 2023Genitourinary CancerOncologyProstate Cancer
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United StatesDecember 1, 2022Genitourinary CancerOncology
Is early-onset cancer an emerging global epidemic?October 5, 2022Breast CancerHead & Neck/Thyroid CancersGenitourinary CancerOncology
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalHead & Neck/Thyroid CancersMelanomaGenitourinary Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Concurrent Romiplostim With FOLFIRINOX for Secondary Prevention of Thrombocytopenia in a Patient With Myelodysplastic Syndrome and Pancreatic AdenocarcinomaSeptember 9, 2022Genitourinary CancerOncology
The ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single CenterAugust 12, 2022Genitourinary CancerOncology
